ArticleJournal of medicinal chemistry2026

Discovery of EGT710, an Oral Nonpeptidomimetic Reversible Covalent SARS-CoV-2 Main Protease Inhibitor.

Julien P N Papillon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.